•
Dec 31, 2020

ImmunityBio Q4 2020 Earnings Report

Total Revenue
$21K
Previous year: $9K
+133.3%
EPS
-$0.18
Previous year: -$0.43
-58.1%
Gross Profit
-$147K
Previous year: $920K
-116.0%
Cash and Equivalents
$34.9M
Previous year: $75.8M
-53.9%
Free Cash Flow
-$23.5M
Previous year: -$15.6M
+50.7%
Total Assets
$221M
Previous year: $270M
-17.9%

ImmunityBio

ImmunityBio

ImmunityBio Revenue by Segment